HCW BIOLOGICS INC.

(HCWB)
  Report
Delayed Nasdaq  -  05/16 04:00:00 pm EDT
2.110 USD   +7.11%
05/13Earnings Flash (HCWB) HCW BIOLOGICS Reports Q1 Revenue $3.12M
MT
05/13HCW BIOLOGICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
05/13HCW Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

HCW Biologics Inc.(NasdaqGM:HCWB) added to S&P TMI Index

09/20/2021 | 12:00am EDT

HCW Biologics Inc.(NasdaqGM:HCWB) added to S&P TMI Index


© S&P Capital IQ 2021
All news about HCW BIOLOGICS INC.
05/13Earnings Flash (HCWB) HCW BIOLOGICS Reports Q1 Revenue $3.12M
MT
05/13HCW BIOLOGICS INC. Management's Discussion and Analysis of Financial Condition and Res..
AQ
05/13HCW Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/13HCW Biologics Reports First Quarter 2022 Financial Results and Recent Business Highligh..
GL
05/13HCW Biologics Reports First Quarter 2022 Financial Results and Recent Business Highligh..
AQ
05/05HCW Biologics to Showcase Two Novel Groups of Fusion Molecules Created with Proprietary..
GL
05/05HCW Biologics to Showcase Two Novel Groups of Fusion Molecules Created with Proprietary..
AQ
04/19HCW Biologics' CEO Hing C. Wong, Ph.D., to be Featured Speaker at the Third Annual Inte..
AQ
03/29HCW BIOLOGICS INC. Management's Discussion and Analysis of Financial Condition and Res..
AQ
03/29HCW Biologics Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
More news
Analyst Recommendations on HCW BIOLOGICS INC.
More recommendations
Financials (USD)
Sales 2022 - - -
Net income 2022 -18,3 M - -
Net Debt 2022 - - -
P/E ratio 2022 -3,30x
Yield 2022 -
Capitalization 75,5 M 75,5 M -
Capi. / Sales 2022 -
Capi. / Sales 2023 -
Nbr of Employees 44
Free-Float 25,0%
Chart HCW BIOLOGICS INC.
Duration : Period :
HCW Biologics Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HCW BIOLOGICS INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 2,11 $
Average target price 7,00 $
Spread / Average Target 232%
EPS Revisions
Managers and Directors
Hing C. Wong Chief Executive Officer, Secretary & Director
Rebecca Byam Chief Financial Officer
Scott T. Garrett Chairman
Peter R. Rhode Chief Scientific Officer & VP-Clinical Operations
Rick Scott Greene Independent Director
Sector and Competitors
1st jan.Capi. (M$)
HCW BIOLOGICS INC.-9.05%71
GILEAD SCIENCES, INC.-14.10%78 232
REGENERON PHARMACEUTICALS, INC.2.22%69 552
VERTEX PHARMACEUTICALS12.35%63 100
WUXI APPTEC CO., LTD.-16.67%43 023
BIONTECH SE-38.39%38 601